Gregory’s Pediatric Anesthesia
Chapter 30 - References
1. Parker SE, Mai CT, Strickland MJ et al. Multistate study of the epidemiology of clubfoot. Birth
Defects Res A Clin Mol Teratol 2009; 85(11): 897–904.
2. Patel M, Herzenberg J. Clubfoot. 2010. http://emedicine.webscape.com/article/1237077–
overview.
3. Simons GW. Calcaneocuboid joint deformity in talipes equinovarus: an overview and update.
J Pediatr Orthop B 1995; 4:25–35.
4. Cooper DM, Dietz FR. Treatment of idiopathic clubfoot. A thirty-year follow-up note. J Bone
Joint Surg Am 1995; 77:1477–89.
5. Noonan KJ, Richards BS. Nonsurgical management of idiopathic clubfoot. J Am Acad Orthop
Surg 2003; 11:392–402.
6. Hussain FN. The role of the Pirani scoring system in the management of clubfoot by the
Ponseti method. J Bone Joint Surg Br 2007; 89: 561.
7. Ponseti IV. Clubfoot management. J Pediatri Orthop 2000; 20: 699–700.
8. Bor N, Herzenberg JE, Frick SL. Ponseti management of clubfoot in older infants. Clin Orthop
Relat Res 2006; 444: 224–8.#
9. Black MD, Olney B, Vitztum C, Hassanein K. Administering caudal anesthesia at completion
of clubfoot surgery does not affect postoperative use of narcotics. Am J Orthop 2003; 32:
130–2.
10. Weinstein SL, Mubarak SJ, Wenger DR. Developmental hip dysplasia and dislocation. Part I.
J Bone Joint Surg Am 2003; 85: 1823–32.
11. Guille JT, Pizzutillo PD, MacEwen GD. Development dysplasia of the hip from birth to six
months. J Am Acad Orthop Surg 2000; 8: 232–42.
12. McKinnon B, Bosse MJ, Browing WH. Congenital dysplasia of the hip: the lax (subluxatable)
newborn hip. J Pediatr Orthop 1984; 4: 422–6.
13. Pavlik A. The functional method of treatment using a harness with stirrups as the primary
method of conservative therapy for infants with congenital dislocation of the hip. Clin Orthop
1992; 281: 4–10.
14. Gage JR, Winter RB. Avascular necrosis of the capital femoral epiphysis as a complication of
the closed reduction of congenital dislocation of the hip. A critical review of twenty years’
experience at Gillette Children’s Hospital. J Bone Joint Surg Am 1972; 54: 373–88.
15. Quinn RH, Renshaw TS, DeLuca PA. Preliminary traction in the treatment of developmental
dislocation of the hip. J Pediatr Orthop 1994; 14: 636–42.
16. Gillingham BL, Sanchez MC, Wenger DR. Pelvic osteotomies for the treatment of hip
dysplasia in children and young adults. J Am Acad Orthop Surg 1999; 7: 325–37.
17. Galpin RD, Roach JW, Wenger DR et al. One-stage treatment of congenital dislocation of
the hip in older children, including femoral shortening. J Bone Joint Surg Am 1989; 71: 734–
41.
18. Tonnis D. An evaluation of conservative and operative methods in the treatment of
congenital hip dislocation. Clin Orthop 1976; 119: 76–88.
19. Wheeles C. Hip spica cast. www.wheelsessonline.com/ortho/hip_spica_cast.
20. Miller ME, Bramlet KW, Kissell EU, Niemann KM. Improved treatment of femoral shaft
fractures in children. The “pontoon” 90–90 spica cast. Clin Orthop 1987; 219: 140–6.
21. Blount WP. Tibia vara, osteochondrosis deformans tibiae. J Bone Joint Surg 1937; 19: 1–29.
22. Bradway JK, Klassen RA, Peterson HA. Blount disease: a review of the English literature. J
Pediatr Orthop 1987; 7: 472–80.
23. DeOrio MJ, DeOrio JK. Blount disease: treatment.
http://emedicine.medscape.com/article/1250420.
24. Hofmann A, Jones RE, Herring JA. Blount’s disease after skeletal maturity. J Bone Joint
Surg Am 1982; 64: 1004–9.
25. Henderson RC. Tibia vara: a complication of adolescent obesity. J Pediatr 1992; 121: 482–6.
26. Sabharwal S, Zhao C, McClemens E. Correlation of body mass index and radiographic
deformities in children with Blount disease. J Bone Joint Surg Am 2007; 89: 1275–83.
27. Zionts LE, Shean CJ. Brace treatment of early infantile tibia vara. J Peditr Orthop 1998; 18:
102–9.
28. Rab GT. Oblique tibial osteotomy for Blount’s disease. J Pediatr Orthop 1988; 8: 715–20.
29. Andrade N, Johnston CE. Medial epiphysiolysis in severe infantile tibia vara. J Pediatr
Orthop 2006; 26: 652–8.
30. Birch JG, Buech MF, Roach JW. Lateral tibia epiphysiodesis for adolescent Blount’s disease.
Orthop Trans 1992; 16: 14.
31. Loder RT. The demographics of slipped capital femoral epiphysis. An international
multicenter study. Clin Orthop 1996; 322: 8–27.
32. Loder RT, Wittenberg B, DeSilva G. Slipped capital femoral epiphysis associated with
endocrine disorders. J Pediatr Orthop 1995; 15: 349–56.
33. Loder RT, Hensinger RN. Slipped capital femoral epiphysis associated with renal failure
osteodystrophy. J Pediatr Orthop 1997; 17: 205–11.
34. Murray AW, Wilson NI. Changing incidence of slipped capital femoral epiphysis: a
relationship with obesity? J Bone Joint Surg Br 2008; 90: 92–4.
35. Kennedy JG, Hresko MT, Kasser JR et al. Osteonecrosis of the femoral head associated
with slipped capital femoral epiphysis. J Pediatr Orthop 2001; 21: 189–93.
36. Peterson MD, Weiner DS, Green NE, Terry CL. Acute slipped capital femoral epiphysis: the
value and safety of urgent manipulative reduction. J Pediatr Orthop 1997; 17: 648–54.
37. Gholve PA, Cameron DB, Millis MB. Slipped capital femoral epiphysis update. Curr Opin
Pediatr 2009; 21: 39–45.
38. Jerre R, Billing L, Hansson G, Wallin J. The contralateral hip in patients primarily treated for
unilateral slipped upper femoral epiphysis. Long-term follow-up of 61 hips. J Bone Joint Surg
Br 1994; 76: 563–7.
39. Riad J, Bajelidze G, Gabos PG. Bilateral slipped capital femoral epiphysis: predictive factors
for contralateral slip. J Pediatr Orthop 2007; 27: 411–14.
40. Weiner DS, Weiner S, Melby A, Hoyt WA Jr. A 30-year experience with bone graft
epiphysiodesis in the treatment of slipped capital femoral epiphysis. J Pediatr Orthop 1984;
4: 145–52.
41. Ikuta Y. Thumb duplication. In: Buck-Gramcko D (ed) Congenital Malformations of the Hand
and Forearm. London: Churchill Livingstone, 1998, pp. 225–35.
42. Manske PR, Goldfarb CA. Congenital failure of formation of the upper limb. Hand Clin 2009;
25: 157–70.
43. Kozin SH. Upper-extremity congenital anomalies. J Bone Joint Surg Am 2003; 85A: 1564–
76.
44. Netscher DT, Scheker LR. Timing and decision-making in the treatment of congenital upper
extremity deformities. Clin Plast Surg 1990; 17: 113–31.
45. McCarroll HR. Congenital anomalies: a 25-year overview. J Hand Surg Am 2000; 25: 1007–
37.
46. Laub DR Jr, Ladd AL, Hentz VR. Congenital hand anomalies. In: Russell RC (ed) Plastic
Surgery: Indications, Operations and Outcomes, vol. IV. St Louis, MO: Mosby, 2000, pp.
1735–48.
47. Netscher DT. Congenital hand problems. Terminology, etiology, and management. Clin Plast
Surg 1998; 25: 537–52.
48. Wood VE. Congenital thumb deformities. Clin Orthop 1985; 195: 7–25.
49. James MA, McCarroll HR Jr, Manske PR. The spectrum of radial longitudinal deficiency: a
modified classification. J Hand Surg Am 1999; 24: 1145–55.
50. Netscher DT, Baumholtz MA. Treatment of congenital upper extremity problems. Plast
Reconstr Surg 2007; 119:101e–129e.
51. Evans H, Steele MS, Nielsen KC et al. Peripheral nerve blocks and continuous catheter
techniques. Anesthesiol Clin North Am 2005; 23: 141–62.
52. Rawal N, Allvin R, Amilon A et al. Postoperative analgesia at home after amulatory hand
surgery: a controlled comparison of tramadol, metamizol, and paracetamol. Anesth Analg
2001; 92: 347–51.
53. Rose JB, Finkel JC, Arquedas-Mohs A et al. Oral tramadol for the treatment of pain of 7–30
days duration in children. Anesth Analg 2003; 96: 78–81.
54. Loder RT, O’Donnell PW, Feinber JR. Epidemiology and mechanism of femur fractures in
children. J Pediatr Orthop 2006; 26: 561–66.
55. Kasser JR, Beaty JH. Femoral shaft fractures. In: Beaty JH, Kasser JR (eds) Fractures in
Children. Philadelphia: Lippincott Williams and Wilkins, 2006, pp. 893–936.
56. Anglen J, Choi L. Treatment options in pediatric femoral shaft fractures. J Orthop Trauma
2005; 19: 724–33
57. Epps HR, Molenaar E, O’Connor DP. Immediate single-leg spica cast for pediatric femoral
diaphysis fractures. J Pediatr Orthop 2006; 26: 491–6.
58. Buehler KC, Thompson JD, Sonseller PD et al. A prospective study of early spica casting
outcomes in the treatment of femoral shaft fractures in children. J Pediatr Orthop 1995; 15:
30–5.
59. Crist BD, della Rocca GJ, Murtha YM. Treatment of acute distal femur fractures. Orthopedics
2008; 31: 681–90.
60. Heinrich SD, Dravaric DM, Darr K, MacEwen GD. The operative stabilization of pediatric
diaphyseal femur fractures with flexible intramedullary nails: a prospective analysis. J
Pediatr Orthop 1994; 14: 501–7.
61. Bar-On E, Sagiv S, Porat S. External fixation or flexible intramedullary nailing for femoral
shaft fractures in children. A prospective randomized study. J Bone Joint Surg Br 1997; 79:
975–78.
62. Morshed S, Humphrey M, Corrales LA. Retention of flexible intramedullary nails following
treatment of pediatric femur fractures. Arch Orthop Trauma Surg 1997; 127: 509–14.
63. Rabin SI, Carlson D, Rabin SL. Complications of supracondylar femur fractures. Loyola U
Orthop J 1995; 4: 30–8.
64. Paterson MP, Hoffman EB, Roux P. Severe disseminated staphylococcal disease associated
with osteitis and septic arthritis. J Bone Joint Surg Br 1990; 72: 94–7.
65. Frank G, Mahoney HM, Eppes SC. Musculoskeletal infections in children. Pediatr Clin North
Am 2005; 52: 1083–6.
66. Peltola H, Kallio MJ, Unkila-Kallio L. Reduced incidence of septic arthritis in children by
Hemophilus influenzae type-b vaccination. Implications for treatment. J Bone Joint Surg Br
1998; 80: 471–3.
67. Arnold SR, Elias D, Buckingham SC et al. Changing patterns of acute hematogenous
osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant
Staphylococcus aureus. J Pediatr Orthop 2006; 26: 703–8.
68. Moylett EH, Rossman SN, Epps HR, Demmler GJ. Importance of Kingella kingae as a
pediatric pathogen in the United States. Pediatr Infect Dis J 2000; 19: 263–5.
69. Song J, Letts M, Monson R. Differentiation of psoas muscle abscess from septic arthritis of
the hip in children. Clin Orthop Relat Res 2001; 391: 258–65.
70. Caird MS, Flynn JM, Leung YL et al. Factors distinguishing septic arthritis from transient
synovitis of the hip in children. A prospective study. J Bone Joint Surg Am 2006; 88: 1251–7.
71. Yagupsky P, Bar-Ziv Y, Howard CB, Dagan R. Epidemiology, etiology and clinical features of
septic arthritis in children younger than 24 months. Arch Pediatr Adolesc Med 1995; 149:
537–40.
72. Baujat G, Lebre AS, Cormier-Daire V, Le Merrer M. Osteogenesis imperfecta, diagnosis
information (clinical and genetic classification). Arch Pediatr 2008; 15: 789–91.
73. Sillence D. Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop 1981;
159: 11–25.
74. Glorieux FH, Bishop NJ, Plotkin H et al. Cyclic administration of pamidronate in children with
severe osteogenesis imperfecta. N Engl J Med 1998; 339: 947–52.
75. Zeitlin L, Fassier F, Glorieux FH. Modern approach to children with osteogenesis imperfecta.
J Pediatr Orthop B 2003; 12: 77–87.
76. Jones D, Hosalkar H, Jones S. The orthopaedic management of osteogenesis imperfecta.
Clin Orthop 2002; 16: 374–88.
77. Cole WG. Advances in osteogenesis imperfecta. Clin Orthop 2002; 401: 6–16.
78. Burnett YL, Brennan MP, Klowden AJ et al. Pulse oximetry and blood pressure monitoring:
effect of automatic tourniquets and automatic noninvasive blood pressure devices on
inducing fractures in pediatric patients with osteogenesis imperfecta. Anesthesiology 1994;
81(3A): A508.
79. Darin N, Kimber E, Kroksmark AK, Tulinius M. Multiple congenital contractures: birth
prevalence, etiology, and outcome. J Pediatr 2002; 140: 61–7.
80. Hall JG. Arthrogryposis multiplex congenita: etiology, genetics, classification, diagnostic
approach, and general aspects. J Pediatr Orthop B 1997; 6: 159–66.
81. Chen H, Blackburn WR, Wertelecki W. Fetal akinesia and multiple perinatal fractures. Am J
Med Genet 1995; 55: 472–7.
82. Banker BQ. Neuropathologic aspects of arthrogryposis multiplex congenita. Clin Orthop
1985; 194: 30–43.
83. Mennen U, van Heest A, Ezaki MB et al. Arthrogryposis multiplex congenita. J Hand Surg Br
2005; 30: 468–74.
84. Bamshad M, van Heest AE, Pleasure D. Arthrogryposis: a review and update. J Bone Joint
Surg Am 2009; 91 Suppl 4: 40–6.
85. Bevan WP, Hall JG, Bamshad M et al. Arthrogryposis multiplex congenita (amyoplasia): an
orthopaedic perspective. J Pediatr Orthop 2007; 27: 594–600.
86. Palmer PM, MacEwen GD, Bowen JR, Mathews PA. Passive motion therapy for infants with
arthrogryposis. Clin Orthop Relat Res 1985; 194: 54–9.
87. Thompson GH, Bilenker RM. Comprehensive management of arthrogryposis multiplex
congenita. Clin Orthop 1985; 194: 6–14.
88. Staheli LT, Chew DE, Elliott JS. Management of hip dislocations in children with
arthrogryposis. J Pediatr Orthop 1987; 7: 681–5.
89. Bennett JB, Hansen PE, Granberry WM. Surgical management of arthrogryposis in the
upper extremity. J Pediatr Orthop 1985; 5: 281–6.
90. Longo M, Hankins GD. Defining cerebral palsy:pathogenesis, pathophysiology and new
intervention. Minerva Ginecol 2009; 61: 421–9.
91. Delgado MR, Hirtz D, Aisen M et al. Practice parameter: pharmacologic treatment of
spasticity in children and adolescents with cerebral palsy (an evidence-based review): report
of the Quality Standards Subcommittee of the American Academy of Neurology and the
Practice Committee of the Child Neurology Society. Neurology 2010; 74: 336–43.
92. Hepaguslar H, Ozzeybek D, Elar Z. The effect of cerebral palsy on the action of vecuronium
with or without anticonvulsants. Anaesthesia 1999; 54: 593–6.
93. Dierdorf SF, McNieceWL, Rao CC. Effect of succinylcholine on plasma potassium in children
with cerebral palsy. Anesthesiology 1985; 62: 88–90.
94. Theroux MC, Brandom BW, Zagnoev M et al. Dose response of succinylcholine at the
adductor pollicis of children with cerebral palsy during propofol and nitrous oxide anesthesia.
Anesth Analg 1994; 79: 761–5.
95. Martyn JA, White DA, Gronert GA et al. Up- and down-regulation of skeletal muscle
acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822–
43.
96. Theroux MC, Akins RE, Barone C et al. Neuromuscular junctions in cerebral palsy: presence
of extrajunctional acetylcholine receptors. Anesthesiology 2002; 96: 330–5.
97. Driessen J. Neuromuscular and mitochondrial disorders: what is relevant to the
anesthesiologist? Curr Opin Anaesthesiol 2008; 21: 350–5.
98. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia
problem revisited. Pediatr Anesth 2008; 18: 100–6.
99. Footitt EJ, Sinha MD, Raiman JAJ et al. Mitochondrial disorders and general anaesthesia: a
case series and review. Br J Anaesth 2008; 100: 436–41.
100. Ohtani Y, Mike T, Ishitsu T et al. A case of malignant hyperthermia with mitochondrial
dysfunction. Brain Dev 1985; 7: 249.
101. Fricker RM, Raffelsberger T, Rauch-Shorny S et al. Positive malignant hyperthermia
susceptibility in vitro test in a patient with mitochondrial myopath and myoadenylate
deaminase deficiency. Anesthesiology 2002; 97: 1635–37.
102. Laugel V, Cossee M, Matis J et al. Diagnostic approach to neonatal hyptonia: retrospective
study on 144 neonates. Eur J Pediatr 2008; 167: 517–23.
103. Ross AK. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the
undiagnosed hypotonic child (editorial). Pediatr Anesth 2007; 17: 1–6.
104. Veyckemans F. Can inhalation agents be used in the presence of a child with myopathy?
Curr Opin Anaesthesiol 2010; 23: 348–55.
105. Flick RP, Gleich SJ, Herr MMH, Wedel DJ. The risk of malignant hyperthermia in children
undergoing muscle biopsy for suspected neuromuscular disorder. Pediatr Anesth 2007; 17:
22–7.
106. Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular dystrophies.
Anesth Analg 2009; 109: 1043–8.
107. Frosch M, Roth J. New insights in systemic juvenile idiopathic arthritis. Rheumatology 2008;
47: 121–5.
108. Keegan MT, Whatcott BD, Harrison BA. Osteogenesis imperfecta, perioperative bleeding,
and desmopressin. Anesthesiology 2002; 97: 1011–13.